-
Ukraine takes Russia fight to 'scorching sands' of Sahel
-
Hurricane Isaias strengthens en route to US Gulf Coast
-
Chinese AI tool pulled to prevent 'misuse' after South Korea hacks
-
US activists deploy poll volunteers over Trump intimidation fears
-
Asian stocks mostly up as traders weigh AI, oil dips after surge
-
Saint Laurent designer Vaccarello leaves after glittering decade
-
Walking through flames: orangutans rescued in Indonesia fires
-
'Tough to stay here': Nepal flood survivors wait for homes
-
LeBron shines in pre-season debut for re-tooled 76ers
-
Malaysia closes schools in capital, parts of country due to haze
-
Okinawa resolution calls for revision of US forces pact after murder
-
Buccaneers stun Cowboys for first win of NFL season
-
Verdict expected Friday in Mexico trial over murders of Australia, US surfers
-
Activists hope trial will stop 'forever chemicals' at Italy plant
-
New York mayor says asking Trump to withdraw ICE after shooting
-
Guardians rally for 9-5 victory over White Sox to stay alive in MLB playoffs
-
Walking through flames: orangutan rescued in Indonesia fires
-
Asian stocks mixed amid AI concerns, oil dips after surge
-
James shines in pre-season debut for re-tooled 76ers
-
Wallabies expect fast-paced All Blacks in Bledisloe opener
-
Fuel, fertilizer costs strain US farmers' support for Republicans in midterms
-
Tech scammer Elizabeth Holmes focus of documentary by absurdist Nathan Fielder
-
Trump's 'super intelligence' rebrand to sell AI faces uphill battle
-
Climate hopes shift from politics to the courts
-
Fiji demands US provide evidence Chinese official paid bribes for Beijing
-
Will Nobel Peace Prize pick make waves at the White House?
-
More than just football: How scandal-tainted City led Manchester's rebirth
-
Trump rules out new Iran attack before US midterm elections
-
Record Eden Park streak creates tension for All Blacks
-
Far-right influencer shows Israel's coarse political turn
-
EU trade chief seeks 'tangible outcomes' in China talks
-
Seals and sea lions get hearing tested at Australia zoo
-
Man City face Anfield cauldron after guilty Premier League verdicts
-
Mourinho's Real Madrid playing catch-up in Clasico countdown
-
CNN, MS Now, Politico urge judge to extend White House access
-
Joy as USS Lincoln back home after troubled Gulf deployment
-
Trump administration to launch new vaccine research center
-
OpenAI says Iran, Russia influence ops busted
-
Russian strikes kill 30 in Ukraine frontline city, talks set in US
-
Anthropic bans 'cruel' behavior against its Claude AI
-
US military to livestream firing squad execution of Fort Hood shooter
-
Anne Carson's Nobel literature prize 'a proud moment for Canada': PM
-
Aces star Wilson wins record-extending fifth WNBA MVP
-
Montagliani to seek CONCACAF re-election in boost for Infantino: reports
-
Undefeated 49ers seek Seahawks revenge
-
Oil surges, stocks sink on jitters over US plans in Iran war
-
Madrid mourns evicted retiree, 'icon' of Spain housing protests
-
John Cena and Jessica Biel hit the gas in 'Matchbox: The Movie'
-
OpenAI revenue gap report rattles AI stocks
-
US, Ukrainians, Europeans to discuss 'new ideas' to end war
Philips chops back US tariff bill
Dutch medical equipment manufacturer Philips said Tuesday that the impact of US tariffs would be much less than it initially estimated, sending its share price surging.
The company had originally estimated in April that US tariffs could cost it 250 to 300 million euros this year after President Donald Trump unveiled a 20 percent tariff rate for goods from the European Union.
Brussels and Washington reached a deal over the weekend that will see goods from the EU face a baseline 15 percent levy when imported into the United States.
It said Tuesday it now expects between 150 and 200 million euros impact from US tariffs this year.
Chief executive Roy Jakobs said Philips updated "the guidance because we have certainty now around what is happening between the EU and the US."
Shares in Philips jumped more than 10 percent during morning trading, while the Amsterdam market rose around 0.4 percent overall.
The trade deal has come under widespread criticism in Europe as having been lopsided, saddling its manufacturers with a costly 15 percent rate with little in return from the US as certainty is a relative concept given Trump's propensity to change positions.
Jakobs said that certainty "is what we value in" in the deal, while acknowledging "it's a painful additional cost we have to carry".
The company still targets a one to three percent increase in annual sales.
Second quarter net profit fell by 47 percent to 240 million euros, but last year's performance was boosted by exceptional income from insurance payouts linked to long-running issues with its sleep apnoea machines.
Sales slid by 2.8 percent to 4.3 billion euros, although they edged higher on a comparable basis that excludes currency changes. The company also noted orders rose by six percent on a comparable basis.
The appreciation of the euro relative to the dollar and other currencies has been crimping the results of European companies as their revenues abroad result in fewer euros on the balance sheet.
Long known for its light bulbs and television sets, the Dutch company has refocused its business towards medical equipment.
C.Kovalenko--BTB